Assessment of the Safety and Efficacy of the Novel Tetrapeptide ITF-1697 on Infarct Size after Primary PTCA in Acute Myocardial Infarction: A Randomised, Placebo-Controlled Pilot Trial

By Syeda B.   Kiss K.   Modarressy K.   Schönau K.   Schukro C.   Derntl M.   Laggner A.   Sochor H.   Glogar D.  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 141-151

Adis International

Access to resources Recommend Favorite

Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

By Lexis Chris   Wieringa Wouter   Hiemstra Bart   Deursen Vincent   Lipsic Erik   Harst Pim   Veldhuisen Dirk   Horst Iwan  

Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite

Use of Reperfusion Therapies in Elderly Patients with Acute Myocardial Infarction

By Angeja B.G.  

Drugs & Aging, Vol. 18, Iss. 8, 2001-08 ,pp. : 587-596

Adis International

Access to resources Recommend Favorite

Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

Effects of Levosimendan on Myocardial Infarct Size and Hemodynamics in a Closed-Chest Porcine Ischemia–Reperfusion Model

By Busk Martin   Maeng Michael   Kristensen Jens   Berg Jette   Mortensen Ulrik   Nielsen Torsten   Nielsen-Kudsk Jens  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 335-342

Springer Publishing Company

Access to resources Recommend Favorite